FCP
CAH icon

Fidelis Capital Partners’s Cardinal Health CAH Stock Holding History

Fidelis Capital Partners’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Sell
7,643
-48
-0.6% -$9.97K 0.1% 158
2026
Q1 		$1.63M Buy
7,691
+39
+0.5% +$8.4K 0.12% 154
2025
Q4 		$1.57M Sell
7,652
-272
-3% -$51.2K 0.11% 147
2025
Q3 		$1.24M Buy
7,924
+5,923
+296% +$915K 0.1% 166
2025
Q2 		$313K Buy
2,001
+64
+3% +$9.5K 0.03% 340
2025
Q1 		$266K Buy
1,937
+3
+0.2% +$382 0.03% 343
2024
Q4 		$242K Buy
+1,934
New +$226K 0.02% 375

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Fidelis Capital Partners's CAH Position: Q2 2026 in Review

Fidelis Capital Partners reduced its Cardinal Health (CAH) stake by 0.62% in Q2 2026, selling an estimated $9.97K and leaving 7,643 shares worth $1.82M. The position accounts for 0.1% of the portfolio, ranked #158.

Fidelis Capital Partners first reported a position in CAH in Q4 2024 and has held it in 7 quarters since. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Fidelis Capital Partners held 7,643 shares of Cardinal Health worth $1.82M as of Q2 2026.
  • Fidelis Capital Partners sold 48 Cardinal Health shares in Q2 2026, an estimated $9.97K.
  • Cardinal Health made up 0.1% of Fidelis Capital Partners's portfolio in Q2 2026, its #158 holding.
  • Fidelis Capital Partners first reported a position in Cardinal Health in Q4 2024 and has held it in 7 quarters since.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.